Recently, CHU PHARMA officially completed its business registration in Xi'an. The company focuses on "high-quality API export, customized CDMO API manufacturing, and injectable OEM production," based in Shaanxi and expanding its pharmaceutical supply chain business globally.

In its initial stage, the company deeply collaborates with pharmaceutical research resources in Northwest China, focusing on building three fundamental systems: API procurement, quality testing, and foreign trade documentation compliance. It prioritizes mature product categories such as theobromine and basic injectable APIs, cultivating the Southeast Asian and Middle Eastern basic pharmaceutical markets to lay a solid foundation for future global expansion.